
Yellow Acre Farms CEO, Adan Arriaga, announced on Thursday the submission of "Method for Administering Cannabis-Derived Compounds," to the United States Patent and Trademark Office (USPTO).
The technology, developed by YAF's R&D team, is capable of delivering various cannabis-derived compounds to the body with high bioavailability and extended duration of action via a variable molecule size nanoemulsion.